EUVIMEDEUVIMED entdecken
Crossref

Anticancer Activity of Fisetin via KEAP1, DNMT1, and mTOR Axis Against Colon Cancer: An Integrated In Silico, In Vitro, and In Vivo Approach

Satyam Sharma iD, Rajat Mudgal, Sairam Krishnamurthy iD, Sanjiv Singh iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Satyam Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, India. Hauptthemen laut MEDLINE: Flavonols, TOR Serine-Threonine Kinases, Kelch-Like ECH-Associated Protein 1, Colonic Neoplasms. Die Arbeit nennt 71 Literaturangaben. Gefördert von: This work was supported by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proliferation of colon cancer is influenced by alterations in epigenetic, reactive oxygen species (ROS), and dysregulation of signaling pathways, especially via the involvement of DNMT1, mTOR, and KEAP1 axis. The current investigation examined the antiproliferative capabilities of fisetin (FisT) in a rat model and in colon cancer cell lines HCT116, CT‐26, and Caco‐2. Our findings show that FisT modulated the DNMT1, mTOR, KEAP1, and IL‐6 signaling pathways to enhance the antiproliferative effects against in vitro and in vivo preclinical model. In‐silico based anticancer potential of fisetin were revealed through SwissTargetPrediction, Cytoscape, STRING, Schrodinger, molecular dynamics simulations, KEGG, and network analysis. In‐vitro MTT assay, cell cycle analysis, ROS level, immunocytofluorescence, western blot analysis, and in vivo immunohistofluorescence, western blot analysis, ELISA‐based assays were performed to evaluate anticancer property of fisetin. Our findings revealed that FisT has a strong anticancer property by demethylating DNA, enhancing ROS, KEAP1 level. Simultaneously downregulated the DNMT1 & mTOR expression, and preventing angiogenesis, cell proliferation, invasion, and migration against in vitro & in vivo models. FisT enhances the anticancer response of tumor development and reduces the size of crypt foci. FisT has potential as a cytotoxic drug, improving and intensifying anticancer responses in colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsTOR Serine-Threonine KinasesKelch-Like ECH-Associated Protein 1Colonic NeoplasmsDNA (Cytosine-5-)-Methyltransferase 1Signal TransductionFlavonoidsAntineoplastic AgentsHumansAnimalsRatsHCT116 CellsCell ProliferationMaleCaco-2 Cells

Stichwörter der Autor:innen

DNMT1KEAP1Ki67angiogenesiscolon cancerfisetinmTOR

Substanzen

fisetinFlavonolsTOR Serine-Threonine KinasesKelch-Like ECH-Associated Protein 1DNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanMTOR protein, humanKEAP1 protein, humanFlavonoidsDnmt1 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, India.
  • Department of Pharmacology, Indian Institute of Technology-Banaras Hindu University, Varanasi, India.

ORCID-Profile: Satyam Sharma, Sairam Krishnamurthy, Sanjiv Singh

Förderung

  • This work was supported by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India.

Zitieren

APA

Sharma, S., Mudgal, R., Krishnamurthy, S., & Singh, S. (2025). Anticancer Activity of Fisetin via KEAP1, DNMT1, and mTOR Axis Against Colon Cancer: An Integrated In Silico, In Vitro, and In Vivo Approach. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70391

Vancouver

Sharma S, Mudgal R, Krishnamurthy S, Singh S. Anticancer Activity of Fisetin via KEAP1, DNMT1, and mTOR Axis Against Colon Cancer: An Integrated In Silico, In Vitro, and In Vivo Approach. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70391

BibTeX
@article{Sharma2025,
  author = {Sharma, Satyam and Mudgal, Rajat and Krishnamurthy, Sairam and Singh, Sanjiv},
  title = {Anticancer Activity of Fisetin via KEAP1, DNMT1, and mTOR Axis Against Colon Cancer: An Integrated In Silico, In Vitro, and In Vivo Approach},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70391}
}
Kostenlos starten →